APRAMEYA Latest Share Price (APRAMEYA)
How good is this company?
Overall performance across 5 key dimensions.
APRAMEYA flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Healthy Operating MarginsOPM is structurally strong at 19.8%
- ●High Promoter HoldingPromoters hold 74.0% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.10x
- ●Promoter BuyingPromoters increased holdings by 74.05% QoQ
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Sales ContractionQuarterly sales dropped 0.7% YoY
- ●Poor Capital ReturnsLow ROE of 7.4%
Latest APRAMEYA News
What changed recently?
Recent events, corporate actions, and announcements.
APRAMEYA valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for APRAMEYA, framed against the sector median so the premium or discount is obvious at a glance.
APRAMEYA trades at a P/E of 60.82×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
APRAMEYA technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for APRAMEYA — derived from the latest tape, not yesterday's close.
Pivot points
Insufficient OHLC data to compute pivots.
CPR cannot be computed without OHLC.
APRAMEYA financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for APRAMEYA — consolidated or standalone — with margins, YoY growth and key ratios inline.
APRAMEYA reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹220.86 Cr. and reported EPS of ₹2.65.
| Metric | — | Mar 2026 |
|---|---|---|
| Revenue from Operations | — | 55 |
| Other Income | — | 0 |
| Total Income | — | 56 |
| — | 12 | |
| Gross ProfitDerived | — | 43 |
| Gross Margin %Derived | — | 78.42% |
| — | 33 | |
| EBITDA (Operating Profit)Derived | — | 11 |
| OPM %Derived | — | 19.11% |
| — | 4 | |
| Profit Before Tax (PBT) | — | 7 |
| — | 2 | |
| Effective Tax %Derived | — | 29.63% |
| Total Profit for Period | — | 5 |
| Less: Non-controlling Interests | — | 0 |
| Net Profit (Owner's PAT)Derived | — | 5 |
| Net Profit Margin %Derived | — | 9.25% |
| Earnings Per Share (EPS ₹) | — | 2.68 |
| Diluted Shares Outstanding (Cr) | — | 2 |
| Other Comprehensive Income (Net of Tax) | — | 0 |
| Total Expenses (incl. D&A & Interest) | — | 48 |
| Material Cost % of RevenueDerived | — | — |
| Employee Cost % of RevenueDerived | — | 6.11% |
| Other Cost % of RevenueDerived | — | 53.20% |
| Interest Coverage (x)Derived | — | 2.87x |
| Period | Mar 2026 | Trend |
|---|---|---|
| Revenue from Operations | 55 | |
| Other Income | 0 | |
| Total Income | 56 | |
12 | ||
| Gross ProfitDerived | 43 | |
| Gross Margin %Derived | 78.42% | |
33 | ||
| EBITDA (Operating Profit)Derived | 11 | |
| OPM %Derived | 19.11% | |
4 | ||
| Profit Before Tax (PBT) | 7 | |
2 | ||
| Effective Tax %Derived | 29.63% | |
| Total Profit for Period | 5 | |
| Less: Non-controlling Interests | 0 | |
| Net Profit (Owner's PAT)Derived | 5 | |
| Net Profit Margin %Derived | 9.25% | |
| Earnings Per Share (EPS ₹) | 2.68 | |
| Diluted Shares Outstanding (Cr) | 2 | |
| Other Comprehensive Income (Net of Tax) | 0 | |
| Total Expenses (incl. D&A & Interest) | 48 | |
| Material Cost % of RevenueDerived | — | |
| Employee Cost % of RevenueDerived | 6.11% | |
| Other Cost % of RevenueDerived | 53.20% | |
| Interest Coverage (x)Derived | 2.87x |
APRAMEYA segment analysis : revenue and profit mix.
Disclosed business segments at APRAMEYA with their share of revenue and profit, switchable between consolidated and standalone reporting.
APRAMEYA discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for APRAMEYA.
Our AI distills the core fundamental drivers supporting APRAMEYA, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
What you're getting.
No strengths or opportunities on record.
Key Risks.
No weaknesses or threats on record.
Flip Conditions.
Valuation risk. a P/E above 79 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
APRAMEYA peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — APRAMEYA is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
APRAMEYA chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for APRAMEYA — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
APRAMEYA delivery volume — last 20 sessions of conviction.
No volume or delivery data on record.
APRAMEYA announcements: results, concalls, ratings, M&A.
Filings APRAMEYA sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
APRAMEYA files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 9 documents below.
Shareholders meeting
Aprameya Engineering Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 01, 2026. Further, the…
Shareholders meeting
Aprameya Engineering Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 01, 2026
Disclosure under SEBI Takeover Regulations
Saurabh Kishorbhai Bhatt has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India…
Disclosure under SEBI Takeover Regulations
Saurabh Kishorbhai Bhatt has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India…
Structural Digital Database
Certificate on Structured Digital database for the period from 1st April 2026 to 21st July, 2026
APRAMEYA dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue APRAMEYA has declared, sequenced by announce and record date.
APRAMEYA corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About APRAMEYA: business, sector, key facts.
What APRAMEYA does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
APRAMEYA is a listed Indian equity.
APRAMEYA
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- 3B BLACKBIO DX (3BBLACKBIO) Share PricePeer
- ABBOTT INDIA (ABBOTINDIA) Share PricePeer
- ACUTAAS CHEMICALS (ACUTAAS) Share PricePeer
- ANLON HEALTHCARE (AHCL) Share PricePeer
- AMANTA (AMANTA) Share PricePeer
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about APRAMEYA (APRAMEYA).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of APRAMEYA (APRAMEYA)?
The current share price of APRAMEYA (APRAMEYA) is ₹0.00. Today, the stock has gained by ₹0.00 (0%), trading in a range of ₹0.00 to ₹0.00. The stock opened at ₹0.00 with a trading volume of 0 shares.
02Is APRAMEYA stock a good investment for long-term?
APRAMEYA can be considered for long-term investment based on several factors. The company has a market capitalization of ₹220.86 Cr., P/E ratio of 60.82, ROE of 7.37%, and ROCE of 10.07%. The dividend yield stands at 0%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03Should I buy APRAMEYA stock at the current price?
Whether to buy APRAMEYA stock at ₹0.00 depends on multiple factors. The stock is currently trading with a P/E ratio of 60.82 and P/B ratio of 0. Today's performance shows a gain of 0%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
04What is the dividend yield of APRAMEYA and when is the next dividend?
APRAMEYA offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹0.00, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
05What are the key financial ratios and metrics of APRAMEYA?
APRAMEYA's key financial metrics include: P/E Ratio: 60.82, P/B Ratio: 0, ROE: 7.37%, ROCE: 10.07%, Dividend Yield: 0%, EPS: ₹2.65, Book Value: ₹36.54, and Debt-to-Equity: 0.1. The company's market cap stands at ₹220.86 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
06How is APRAMEYA stock performing today in the market?
APRAMEYA stock opened at ₹0.00 and is currently trading at ₹0.00, showing a gain of ₹0.00 (0%). The intraday high is ₹0.00 and low is ₹0.00. The trading volume stands at 0 shares, indicating moderate market participation today.
07What is the P/E ratio of APRAMEYA and what does it indicate?
APRAMEYA has a Price-to-Earnings (P/E) ratio of 60.82, which means investors are willing to pay 60.82 for every ₹1 of earnings. With an EPS of ₹2.65, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
08What is the market capitalization of APRAMEYA?
APRAMEYA has a market capitalization of ₹220.86 Cr., making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹0.00) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
The data, ratios and commentary about APRAMEYA (APRAMEYA) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.